Incannex Healthcare (NASDAQ:IXHL) Releases Earnings Results

Incannex Healthcare (NASDAQ:IXHL) posted its quarterly earnings results on Friday. The company reported ($0.33) EPS for the quarter, Zacks reports.

Incannex Healthcare Stock Performance

Shares of Incannex Healthcare stock traded down $0.02 during trading on Friday, hitting $1.78. 37,933 shares of the stock traded hands, compared to its average volume of 86,802. The company has a fifty day moving average price of $1.85 and a two-hundred day moving average price of $1.92. Incannex Healthcare has a twelve month low of $1.50 and a twelve month high of $8.47. The stock has a market cap of $31.40 million, a P/E ratio of -1.28 and a beta of 7.44.

About Incannex Healthcare

Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.